Stock NVDL NOVADEL PHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Novadel Pharma Inc

Equities

NVDL

US66986X1063

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Novadel Pharma Inc

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NovaDel Pharma Inc. : Announces Dissolution of the Company
BU
Novadel Pharma : Reports Resolution of Contingent Liabilities
BU
Novadel Pharma : Announces Update to Agreement with Amherst Pharmaceuticals
BU
Novadel Pharma : Announces the Sale of Its ZolpiMist® New Drug Application, License and Intellectual Property to Amherst Pharmaceuticals, LLC
BU
Novadel Pharma : Announces Proposed Actions to Complete Liquidation of Assets and Cash Distribution to Shareholders
BU
Novadel Pharma Inc : NovaDel Announces the Sale of its NitroMist® New Drug Application, License and Intellectual Property to Mist Pharmaceuticals, LLC.
BU
Novadel Pharma Inc : NovaDel Announces Completion of the Sale of Substantially All Assets to Suda Ltd.
BU
Novadel Pharma Inc : NovaDel Announces Stockholder Approval of Sale of Substantially All Assets to Suda Ltd.
BU
Novadel Pharma Inc : NovaDel Announces Adjournment of Special Stockholder Meeting
BU
Novadel Pharma Inc : NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist? Technology and Certain Other Assets
BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Twelve Months Ended December 31, 2012
BU
Novadel Pharma Inc : NovaDel Announces Preliminary Agreement to Sell its NovaMist(tm) Technology
PU
Novadel Pharma Inc : NovaDel Announces Preliminary Agreement to Sell its NovaMist? Technology
BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Nine Months Ended September 30, 2012
BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Six Months Ended June 30, 2012
BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for Fourth Quarter and Year Ended December 31, 2011
BU
Novadel Pharma Inc : NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product
BU
Novadel Pharma Inc : NovaDel Continuing to Explore Strategic Alternatives
BU
Novadel Pharma Inc : NovaDel Reports Financial Results for Third Quarter 2011
BU
NOVADEL PHAMA : NovaDel Pharma Inc. Recent Events
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NVDL Stock
  4. News Novadel Pharma Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW